Marc van der Schee at the 2020 Breath Biopsy Conference

Please note, this presentation includes part of a video created by Kurzgesagt.org

The 2021 Breath Biopsy Conference is scheduled for 12th & 13th October. Click the button to express interest in the next Breath Biopsy Conference:

Express Interest

Talk Abstract:

In less than a year, SARS-Cov-2 has had a truly global impact, affecting almost every aspect of human life. More than 40 million people have now been infected, and over 1 million lives lost. This has created an unprecedented need for rapid, reliable and sensitive disease detection. In this context both the measurement of exhaled metabolites (VOCs) and direct detection of virus in exhaled aerosols have received considereable attention. In this presentation we will discuss some of the approaches Owlstone has taken to explore the accuracy of breath in the context of SARS-Cov-2 detection. This includes evaluation of a specific breath aerosol collector as well as its technical and clinical validation. At the end of this presentation you will have a better understanding of the pitfalls and opportunities around breath analysis for COVID and respiratory infections more broadly.

Speaker Biography:
Marc van der Schee has close to 10 years of experience in the field of volatile biomarker research. During his PhD Marc pioneered the use of exhaled breath analysis in Lung Cancer, Asthma and Colorectal Cancer amongst others. For this work he received various awards including a Marie Curie Fellowship. His background spans both medical, epidemiological, chemical analytical and data-analysis aspects of biomedical research. By building on this expertise he designs and oversees all clinical trials within Owlstone Medical helping to collect data that drives product development and implementation into clinical practice. As a trained medical doctor Marc helps prioritise medical applications and is the primary interface between clinical partners and Owlstone. Marc holds a medical degree and a doctorate in Biomedical Sciences and obtained a PhD degree by studying the use of volatile biomarkers for disease diagnosis, monitoring and prognosis prediction.

The 2021 Breath Biopsy Conference is scheduled for 12th & 13th October. Click the button to express interest in the next Breath Biopsy Conference:

Express Interest